NIM
ABMD

NXG Investment Management’s Abiomed Inc ABMD Stock Holding History

NXG Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-614
Closed -$200K – 124
2021
Q3 		$200K Sell
614
-29
-5% -$9.82K 0.02% 108
2021
Q2 		$201K Sell
643
-2,366
-79% -$726K 0.02% 111
2021
Q1 		$959K Buy
3,009
+361
+14% +$116K 0.11% 83
2020
Q4 		$858K Hold
2,648
– – 0.1% 94
2020
Q3 		$734K Buy
2,648
+333
+14% +$95.9K 0.11% 67
2020
Q2 		$559K Sell
2,315
-1,343
-37% -$270K 0.06% 87
2020
Q1 		$531K Buy
3,658
+2,371
+184% +$394K 0.07% 70
2019
Q4 		$220K Buy
1,287
+48
+4% +$8.9K 0.01% 121
2019
Q3 		$220K Buy
+1,239
New +$268K 0.01% 110

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NXG Investment Management's ABMD Position: Q4 2021 in Review

NXG Investment Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 614 shares — an estimated $200K sold.

NXG Investment Management first reported a position in ABMD in Q3 2019 and held it in 9 quarters. The position peaked at $959K in Q1 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • NXG Investment Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • NXG Investment Management sold 614 Abiomed Inc shares in Q4 2021, an estimated $200K.
  • NXG Investment Management first reported a position in Abiomed Inc in Q3 2019 and held it in 9 quarters.
  • NXG Investment Management's Abiomed Inc position peaked at $959K in Q1 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on NXG Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.